two businessmen signing a contract stock illustration warrants

Warrants and Venture Debt

What are warrants?

A warrant is a type of security that give the holder the right to buy a predetermined portion of company stock at a fixed price until the expiration date. They may – but don’t necessarily – cause dilution, since the company must issue stock if a warrant is exercised.

The predetermined price at which a holder can buy stock is called the exercise price of a warrant. The time period during which the warrant can be exercised is called the expiration date.

Warrants in venture debt deals

Venture debt, or venture lending, is a type of financing for venture equity-backed companies that lack the cash-flow or assets for more common forms of debt financing or that want greater flexibility.

A warrant can be beneficial to both investors and entrepreneurs. Investors may be more likely to invest in a deal with warrants, since it allows an investor to participate in a company’s growth, even after a company repays their investment. Companies may issue them to make the terms of the deal more favorable for them by bringing down the cost of capital.

Advantages and disadvantages for my software company 

Advantages:

  • Can use warrants to negotiate for lower cost of capital
  • Potential additional source of capital if exercised

Disadvantages:

  • Increases dilution if exercised

When discussing a venture debt deal, consider what the most important aspects of the deal are to you. If the interest rate is your top priority, it may be beneficial to leverage the use of warrants for a lower cost of capital deal. Alternatively, if minimizing dilution is your highest priority, issuing a warrant may not make sense for your company.

Does Novel use warrants? 

Roughly half of Novel’s deals include warrants. While a warrant can extend up to 20%, coverage at Novel ranges from 0.25%-1%. The incorporation of a warrant in a deal can allow for flexibility on other aspects of a deal, such as the royalty rate or repayment cap.

Back to the Growth Center

Related Posts

Debt, Equity, or Both? A Cost of Capital Framework for Founders

Every founder eventually asks some version of the same question: should I raise equity, take on debt, or do both? Most founders answer it by comparing which instrument looks cheaper on paper. That is the wrong question. The real question is whether the return you can generate on a dollar justifies what that dollar actually costs you. This came up in a recent webinar, From Capital Planning to Capital Execution,

How Long Does Fundraising Take? Where the Six to Twelve Months Actually Goes

Ask a founder how long their raise will take and you will usually hear one month, maybe two, maybe three. Ask again four months in and the answer has changed. Carlos Antequera, our co-founder and CEO, names the pattern this way: because founders are optimistic by nature, they tend to think it happens in the next month, two, three. On average, most fundraising processes run six to twelve months. That

Revenue-Based Financing Eligibility and Sizing for B2B SaaS Companies ($5M+ ARR)

A B2B software company above $5 million in ARR clears most providers’ minimums comfortably, so the live questions are what underwriting actually examines and how much capital that revenue supports. This guide covers the underwriting basis, the published eligibility criteria, the amount available at this revenue band, and how existing debt affects capacity. Novel Capital sizes Upfront Capital to 15% to 20% of gross profit margin, from $100,000 to $2

Financing a B2B SaaS Company Through an Exit Process ($5M+ ARR)

A company above $5 million in ARR planning toward a sale needs capital that behaves predictably across a timeline nobody can forecast, and the terms that matter most are the ones that only come up in a transaction. This guide covers what happens to a facility if the company is acquired, whether draws stay available once a process is underway, how a facility compares with an equity bridge, and how

Related Posts